CO6140054A2 - Compuestos de dialquilfenilo con actividad agonista del receptor beta2 adrenergico y antagonista del receptor muscarinico - Google Patents
Compuestos de dialquilfenilo con actividad agonista del receptor beta2 adrenergico y antagonista del receptor muscarinicoInfo
- Publication number
- CO6140054A2 CO6140054A2 CO08115666A CO08115666A CO6140054A2 CO 6140054 A2 CO6140054 A2 CO 6140054A2 CO 08115666 A CO08115666 A CO 08115666A CO 08115666 A CO08115666 A CO 08115666A CO 6140054 A2 CO6140054 A2 CO 6140054A2
- Authority
- CO
- Colombia
- Prior art keywords
- dialquilphenyl
- compounds
- receptor agonist
- adrenergic receptor
- agonist activity
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
1.- Un compuesto de fórmula I:CARACTERIZADO PORQUE R1 es metilo o etilo; R2 es metilo o etilo; o una sal o solvato o estereoisómero del mismo aceptable para uso farmacéutico. 2.- Un compuesto de la reivindicación 1 con fórmula II:CARACTERIZADO PORQUE R1 es metilo o etilo; R2 es metilo o etilo; o una sal del mismo aceptable para uso farmacéutico. 3.- Un compuesto de la reivindicación 1 CARACTERIZADO PORQUE tiene la fórmula IIa:4.- Un compuesto de la reivindicación 1 CARACTERIZADO PORQUE el compuesto es una sal de un compuesto de fórmula I aceptable para uso farmacéutico la:5.- Una composición farmacéutica CARACTERIZADA PORQUE comprende un vehículo aceptable para uso farmacéutico y un compuesto de cualquiera de las reivindicaciones 1 a 4.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US79470206P | 2006-04-25 | 2006-04-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
CO6140054A2 true CO6140054A2 (es) | 2010-03-19 |
Family
ID=38577470
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO08115666A CO6140054A2 (es) | 2006-04-25 | 2008-10-29 | Compuestos de dialquilfenilo con actividad agonista del receptor beta2 adrenergico y antagonista del receptor muscarinico |
Country Status (20)
Country | Link |
---|---|
US (3) | US7524965B2 (es) |
EP (1) | EP2010489B1 (es) |
JP (1) | JP2009541209A (es) |
KR (1) | KR20090005389A (es) |
CN (1) | CN101426764A (es) |
AR (1) | AR060647A1 (es) |
AU (1) | AU2007243481A1 (es) |
BR (1) | BRPI0710767A2 (es) |
CA (1) | CA2650530A1 (es) |
CO (1) | CO6140054A2 (es) |
ES (1) | ES2391584T3 (es) |
IL (1) | IL194334A0 (es) |
MA (1) | MA30556B1 (es) |
MX (1) | MX2008013555A (es) |
NO (1) | NO20084603L (es) |
PE (1) | PE20080094A1 (es) |
RU (1) | RU2008146383A (es) |
TW (1) | TW200811105A (es) |
WO (1) | WO2007127196A2 (es) |
ZA (1) | ZA200808817B (es) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6693202B1 (en) * | 1999-02-16 | 2004-02-17 | Theravance, Inc. | Muscarinic receptor antagonists |
PE20040950A1 (es) * | 2003-02-14 | 2005-01-01 | Theravance Inc | DERIVADOS DE BIFENILO COMO AGONISTAS DE LOS RECEPTORES ADRENERGICOS ß2 Y COMO ANTAGONISTAS DE LOS RECEPTORES MUSCARINICOS |
TWI341836B (en) | 2004-03-11 | 2011-05-11 | Theravance Inc | Biphenyl compounds useful as muscarinic receptor antagonists |
US7528253B2 (en) * | 2004-08-16 | 2009-05-05 | Theravance, Inc. | Compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
TW200811105A (en) * | 2006-04-25 | 2008-03-01 | Theravance Inc | Dialkylphenyl compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
TW200811104A (en) * | 2006-04-25 | 2008-03-01 | Theravance Inc | Crystalline forms of a dimethylphenyl compound |
MY149731A (en) * | 2008-02-06 | 2013-10-14 | Astrazeneca Ab | Compounds |
PT2599778T (pt) | 2009-04-23 | 2017-06-06 | Theravance Respiratory Co Llc | Compostos de diamida possuindo actividade antagonista do receptor muscarínico e agonista do receptor adrenérgico beta 2 |
HUE044653T2 (hu) | 2009-07-22 | 2019-11-28 | PureTech Health LLC | Készítmények olyan rendellenességek kezelésére, amelyek muszkarin-receptor aktiválással enyhíthetõk |
US10265311B2 (en) | 2009-07-22 | 2019-04-23 | PureTech Health LLC | Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation |
WO2011081937A1 (en) | 2009-12-15 | 2011-07-07 | Gilead Sciences, Inc. | Corticosteroid-beta-agonist-muscarinic antagonist compounds for use in therapy |
GB201009801D0 (en) | 2010-06-11 | 2010-07-21 | Astrazeneca Ab | Compounds 950 |
CA3180743A1 (en) | 2018-09-28 | 2020-04-02 | Karuna Therapeutics, Inc. | Composition comprising xanomeline and trospium for treating disorders ameliorated by muscarinic receptor activation |
CN114409556A (zh) * | 2022-01-28 | 2022-04-29 | 兰州康鹏威耳化工有限公司 | 一种3,4-二取代-2-氨基苯甲醛的制备方法 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995006635A1 (fr) | 1993-09-02 | 1995-03-09 | Yamanouchi Pharmaceutical Co., Ltd. | Derive de carbamate et medicament le contenant |
WO1995021820A1 (fr) | 1994-02-10 | 1995-08-17 | Yamanouchi Pharmaceutical Co., Ltd. | Nouveau derive du carbamate et composition correspondante |
US6040344A (en) * | 1996-11-11 | 2000-03-21 | Sepracor Inc. | Formoterol process |
US6541669B1 (en) * | 1998-06-08 | 2003-04-01 | Theravance, Inc. | β2-adrenergic receptor agonists |
US6693202B1 (en) * | 1999-02-16 | 2004-02-17 | Theravance, Inc. | Muscarinic receptor antagonists |
DE19921693A1 (de) | 1999-05-12 | 2000-11-16 | Boehringer Ingelheim Pharma | Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika |
UA73965C2 (en) * | 1999-12-08 | 2005-10-17 | Theravance Inc | b2 ADRENERGIC RECEPTOR ANTAGONISTS |
US7045658B2 (en) | 2001-03-22 | 2006-05-16 | Glaxo Group Limited | Formailide derivatives as beta2-adrenoreceptor agonists |
US20030018019A1 (en) * | 2001-06-23 | 2003-01-23 | Boehringer Ingelheim Pharma Kg | Pharmaceutical compositions based on anticholinergics, corticosteroids and betamimetics |
TWI249515B (en) * | 2001-11-13 | 2006-02-21 | Theravance Inc | Aryl aniline beta2 adrenergic receptor agonists |
PE20040950A1 (es) | 2003-02-14 | 2005-01-01 | Theravance Inc | DERIVADOS DE BIFENILO COMO AGONISTAS DE LOS RECEPTORES ADRENERGICOS ß2 Y COMO ANTAGONISTAS DE LOS RECEPTORES MUSCARINICOS |
CA2543858C (en) * | 2003-11-21 | 2014-04-15 | Theravance, Inc. | Compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
JP2007528416A (ja) * | 2004-03-11 | 2007-10-11 | セラヴァンス, インコーポレーテッド | ムスカリンレセプターアンタゴニストとしての有用なビフェニル化合物 |
TWI374883B (en) * | 2004-08-16 | 2012-10-21 | Theravance Inc | Crystalline form of a biphenyl compound |
US7528253B2 (en) * | 2004-08-16 | 2009-05-05 | Theravance, Inc. | Compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
JP2008510015A (ja) * | 2004-08-16 | 2008-04-03 | セラヴァンス, インコーポレーテッド | β2アドレナリン作用性レセプターアゴニスト活性およびムスカリン性レセプターアンタゴニスト活性を有する化合物 |
TW200811104A (en) * | 2006-04-25 | 2008-03-01 | Theravance Inc | Crystalline forms of a dimethylphenyl compound |
TW200811105A (en) * | 2006-04-25 | 2008-03-01 | Theravance Inc | Dialkylphenyl compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
-
2007
- 2007-04-23 TW TW096114175A patent/TW200811105A/zh unknown
- 2007-04-24 WO PCT/US2007/009925 patent/WO2007127196A2/en active Application Filing
- 2007-04-24 KR KR1020087028589A patent/KR20090005389A/ko not_active Application Discontinuation
- 2007-04-24 MX MX2008013555A patent/MX2008013555A/es active IP Right Grant
- 2007-04-24 US US11/789,300 patent/US7524965B2/en active Active
- 2007-04-24 AU AU2007243481A patent/AU2007243481A1/en not_active Abandoned
- 2007-04-24 AR ARP070101777A patent/AR060647A1/es unknown
- 2007-04-24 ES ES07776093T patent/ES2391584T3/es active Active
- 2007-04-24 EP EP07776093A patent/EP2010489B1/en active Active
- 2007-04-24 BR BRPI0710767-6A patent/BRPI0710767A2/pt not_active IP Right Cessation
- 2007-04-24 PE PE2007000509A patent/PE20080094A1/es not_active Application Discontinuation
- 2007-04-24 JP JP2009507757A patent/JP2009541209A/ja active Pending
- 2007-04-24 CA CA002650530A patent/CA2650530A1/en not_active Abandoned
- 2007-04-24 CN CNA2007800140984A patent/CN101426764A/zh active Pending
- 2007-04-24 RU RU2008146383/04A patent/RU2008146383A/ru not_active Application Discontinuation
-
2008
- 2008-09-25 IL IL194334A patent/IL194334A0/en unknown
- 2008-10-15 ZA ZA200808817A patent/ZA200808817B/xx unknown
- 2008-10-29 CO CO08115666A patent/CO6140054A2/es unknown
- 2008-10-30 NO NO20084603A patent/NO20084603L/no not_active Application Discontinuation
- 2008-11-14 MA MA31382A patent/MA30556B1/fr unknown
-
2009
- 2009-03-18 US US12/406,283 patent/US7687521B2/en active Active
-
2010
- 2010-02-05 US US12/701,108 patent/US8134006B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
KR20090005389A (ko) | 2009-01-13 |
NO20084603L (no) | 2008-11-19 |
US8134006B2 (en) | 2012-03-13 |
CN101426764A (zh) | 2009-05-06 |
ES2391584T3 (es) | 2012-11-28 |
EP2010489A2 (en) | 2009-01-07 |
BRPI0710767A2 (pt) | 2011-06-07 |
JP2009541209A (ja) | 2009-11-26 |
US7524965B2 (en) | 2009-04-28 |
WO2007127196A3 (en) | 2007-12-21 |
US20090176833A1 (en) | 2009-07-09 |
ZA200808817B (en) | 2010-03-31 |
US7687521B2 (en) | 2010-03-30 |
AU2007243481A1 (en) | 2007-11-08 |
RU2008146383A (ru) | 2010-05-27 |
PE20080094A1 (es) | 2008-02-17 |
IL194334A0 (en) | 2009-08-03 |
MA30556B1 (fr) | 2009-07-01 |
US20070249675A1 (en) | 2007-10-25 |
US20100137603A1 (en) | 2010-06-03 |
CA2650530A1 (en) | 2007-11-08 |
EP2010489B1 (en) | 2012-08-22 |
TW200811105A (en) | 2008-03-01 |
WO2007127196A2 (en) | 2007-11-08 |
MX2008013555A (es) | 2008-11-04 |
AR060647A1 (es) | 2008-07-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO6140054A2 (es) | Compuestos de dialquilfenilo con actividad agonista del receptor beta2 adrenergico y antagonista del receptor muscarinico | |
AR106942A2 (es) | Compuestos de isoindolina y composiciones farmacéuticas de los mismos | |
AR047076A1 (es) | Compuestos de pirrolotriazina como inhibidores de tirosina quinasas, composiciones farmaceuticas | |
CR9214A (es) | 2-fenilindoles como antagonistas del receptor de la prostaglandina d2 | |
CL2009000815A1 (es) | Compuestos derivados de fenilhidroximetilpirrolidina, agonista del recptor adrenergico beta 3; composicion farmaceutica que los comprende; uso en el tratamiento de vejiga hiperactiva, incontinencia urinaria por impulso y urgencia urinaria. | |
AR049274A1 (es) | Acido2-{[2-(2-metilaminopirimidin-4-il)-1h-indol-5-carbonil]amino}-3-(fenilpiridin-2-ilamino)propionico sustancialmente puro como inhibidor selectivo de la quinasa ikk-2 | |
AR061134A1 (es) | Derivados de tioxantina | |
AR067770A1 (es) | Derivados de tiazol y ditiazol para el tratamiento de diabetes | |
ECSP078003A (es) | Inhibidores de aspartil proteasas | |
PE20091556A1 (es) | Derivado heterociclico fusionado y su uso | |
RS52700B (en) | SUBSTITUTED OXINDOL DERIVATIVE AND ITS USE AS A VASOPRESIN RECEPTOR LIGAND | |
PE20141050A1 (es) | Inhibidores de quinasa relacionados con pirrolo (2,3-d) pirimidina tropomiosina | |
CL2008000836A1 (es) | Compuestos derivados de tiazolidina, antagonistas del receptor de orexina; composicion farmaceutica que los comprende; y su uso en el tratamiento de neurosis emocional, depresion grave, trastornos psicoticos, alzheimer, parkinson, dolor, entre otras. | |
AR050407A1 (es) | Compuestos quinolinon-carboxamida como agonistas del receptor 5-ht4. procesos de obtencion y composiciones farmaceuticas | |
AR066882A1 (es) | Derivados de oxadiazol, una composicion farmaceutica que los comprende y su uso en la preparacion de medicamentos para el tratamiento de trastornos asociados con la disfuncion del glutamato. | |
AR073524A1 (es) | Piridopirimidinonas inhibidores de pi3k a y m tor | |
EA200970585A1 (ru) | Бензамидные производные как агонисты ер-рецепторов | |
CR20110250A (es) | Antagonistas de los receptores de la melacortina | |
EA201101398A1 (ru) | Замещенные пиперидины в качестве антагонистов ccr3 | |
AR060536A1 (es) | Agonista del receptor de glucocorticoides y composiciones farmaceuticas | |
UY30298A1 (es) | Inhibidores de la quinasa c-fms ii | |
ECSP109900A (es) | Derivados de pirimidina utiles para el tratamiento de condiciones inflamatorias o alergicas | |
ECSP077402A (es) | Derivados de 2-amido-4-feniltiazol, su preparación y su aplicación en terapéutica | |
ATE502936T1 (de) | 2, 6-di-(hetero-)aryl-4-amido-pyrimidine als adenosin-rezeptor-antagonisten | |
AR056175A1 (es) | Compuestos de cromano como antagonistas de 5-ht1b |